Updated Jul 16, 2026
Lynch Thomas J. Jr. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Thomas J. Lynch Jr. is a corporate insider associated with Foghorn Therapeutics Inc. based on the company’s SEC filings dated through 2026-06-25. The filings identify him in connection with Foghorn Therapeutics, but public sources do not clearly confirm his exact title (e.g., director, officer) or provide a detailed public biography beyond his SEC reporting role. There is no public information indicating he is deceased as of the filing date.
| Role | Insider |
|---|---|
| Notability | 18/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | NTRA | Natera, Inc. | A — Grant or award | 1.9K | — |
Thomas J. Lynch Jr. is a corporate insider associated with Foghorn Therapeutics Inc. based on the company’s SEC filings dated through 2026-06-25. The filings identify him in connection with Foghorn Therapeutics, but public sources do not clearly confirm his exact title (e.g., director, officer) or provide a detailed public biography beyond his SEC reporting role. There is no pu…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lynch Thomas J. Jr. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.